August 2017

Royal Philips Acquires Spectranetics in $2B Deal

North America - United States | Europe | Europe - Netherlands | United States - Colorado

Royal Philips acquired Spectranetics, a U.S.-based vascular intervention device maker, in a $2.2 billion deal. Spectranetics' portfolio of devices will aid Philips' strategic expansion into therapy devices. Faegre Baker Daniels represented Spectranetics in the acquisition.

Faegre Baker Daniels 网站使用 Cookie 来提升您的浏览体验。